X
Log In
Username or E-mail:
Password:
EULA
Log In
Forgot Password
Sign Up
Sign Up
Username:
E-mail:
Password:
EULA
Sign Up
Forgot Password
Already a Member
Username or E-mail
Send Forgot Mail
Back to Login
EULA
X
Share This!
Sign Up
Log In
Logout
X
English Türkçe

MESO

Closed

Mesoblast Ltd

12.12
+1.23 (+11.29%)
Last Update: 01 Jul 2025 23:00:00
Yesterday: 10.89
Day's Range: 11.72 - 12.5035
Send
When Written:
 
3.34
Mesoblast Ltd is a biopharmaceutical company that focuses on developing regenerative medicine therapies using mesenchymal lineage adult stem cells. The company's lead product candidate, remestemcel-L, is being developed for various inflammatory conditions, including acute graft versus host disease (GVHD), chronic heart failure, and COVID-19-related acute respiratory distress syndrome. Mesoblast also has a pipeline of other product candidates in various stages of development for the treatment of various diseases, including degenerative disc disease, diabetic nephropathy, and rheumatoid arthritis. The company is headquartered in Melbourne, Australia, and has operations in the United States, Singapore, and Europe. Mesoblast was founded in 2004 and went public in 2004.

Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
Contact with us

Mail:
Message:
Cancel
Send
IP Adresiniz:216.73.216.209
X